Access with U.S.-licensed clinicians via telehealth Free Eligibility Assessment GLP-1 and GLP-1 + GIP treatment options Free tracked medication delivery 24/7 Support, Unlimited check-ins TrimRx offers the simplest way to start your GLP-1 weight loss journey without insurance
Last Updated: November 20th, 2025
Both GLP-1R and GIPR agonists conferred robust protection against T2DM, lowered BMI, and improved insulin sensitivity, highlighting their foundational roles in systemic metabolic control
Food and Drug Administration (FDA) issued new label warnings for Ozempic, indicating that it can increase the risk of intestinal blockages
Risk of ophthalmic adverse drug reactions in patients prescribed glucagon-like peptide 1 receptor agonists: A pharmacovigilance study based on the FDA adverse event reporting system database
However, its important to note that real-world outcomes often fall short of clinical trial results due to adherence challenges
